Latest News On Drug Costs

Latest KFF Health News Stories

Timeline: The Orphan Drug Act

KFF Health News Original

Follow the twists and turns of the orphan drug industry over the past three decades.

Interactive: How Orphan Drugs Win The ‘Monopoly’ Game

KFF Health News Original

Check out all the drugs the FDA has approved to treat rare diseases. You can search by brand name, or by disease, and see familiar names that were first sold on the mass market or all the drugs that won FDA approval to treat more than one rare disease.

Millones de personas buscan medicamentos más baratos fuera de EE.UU.

KFF Health News Original

Por los altos precios de los medicamentos, millones de personas, en general respetuosas de la ley, han reaccionado cometiendo un acto ilegal: comprándolos fuera de los Estados Unidos.

Medicare Pays For A Kidney Transplant, But Not The Drugs To Keep It Viable

KFF Health News Original

The federal government pays for kidney transplants. But the program only pays for essential anti-rejection drugs for three years. Many people can’t afford them and can end up losing the kidney.

Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar

KFF Health News Original

The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.

California’s Drug Price Initiative: Will Voters ‘Send A Signal To Washington’?

KFF Health News Original

Despite heavy opposition from the pharmaceutical industry and skepticism from policy experts, many voters see Proposition 61 as a way to protest the nation’s mounting drug prices.

West Virginia Grapples With High Drug Costs

KFF Health News Original

Climbing drug prices are taking a toll on West Virginia’s budget, some state legislators say. Expensive drugs fuel an increase in Medicaid spending, which leaves less money for schools and roads.

7 Insurers Alleged To Use Skimpy Drug Coverage To Discourage HIV Patients

KFF Health News Original

The plans sought to discourage costly HIV patients by not including their drug needs in formularies or requiring high cost sharing, a Harvard Law School group says in a complaint filed with HHS.

A Golden Ticket That Fast-Tracks A Drug Through The FDA

KFF Health News Original

A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.